Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 736 to 750 of 8987 results

  1. Children's social care

    All NICE products on children's social care. Includes any guidance and quality standards.

    Topic page

  2. Adult's social care

    All NICE products on adult's social care. Includes any guidance and quality standards.

    Topic page

  3. Fractures

    All NICE products on fractures. Includes any guidance, advice and quality standards.

    Topic page

  4. Transport

    All NICE products on transport. Includes any guidance.

    Topic page

  5. Digital health

    All NICE products on digital health. Includes any guidance and quality standards.

    Topic page

  6. Organ and tissue transplantation

    All NICE products on organ and tissue transplantation. Includes any guidance, advice and quality standards.

    Topic page

  7. Pressure ulcers

    All NICE products on pressure ulcers. Includes any guidance, advice and quality standards.

    Topic page

  8. Lower urinary tract symptoms

    All NICE products on lower urinary tract symptoms. Includes any guidance, advice and quality standards.

    Topic page

  9. Women's and reproductive health guidelines

    This webpage covers all NICE's guidelines on women's and reproductive health. The table presents the guidelines alphabetically. Updates planned or in...

    NICE guideline
    In development

  10. Breast cancer guidelines

    This webpage covers NICE guidelines on breast cancer. The table below presents the guidelines alphabetically with links to the surveillance report...

    NICE guideline
    In development

  11. Serious eye disorders (QS180)

    This quality standard covers the diagnosis and management of cataracts, glaucoma and age-related macular degeneration (AMD) and the prevention of sight loss. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    12 February 2019
    View quality statements

    Sections for QS180

  12. Osimertinib for maintenance treatment of EGFR mutation-positive unresectable locally advanced non-small-cell lung cancer after platinum-based chemoradiotherapy [ID6223]

    In development Reference number: GID-TA11232 Expected publication date:  20 May 2026

    Technology appraisal guidance
    In development

  13. Cabozantinib for treating advanced neuroendocrine tumours that have progressed after systemic treatment [ID6474]

    In development Reference number: GID-TA11613 Expected publication date:  21 May 2026

    Technology appraisal guidance
    In development

  14. Inhaled treprostinil for treating pulmonary hypertension with interstitial lung disease [ID6459]

    In development Reference number: GID-TA11572 Expected publication date:  21 May 2026

    Technology appraisal guidance
    In development

  15. Mitapivat for treating pyruvate kinase deficiency (terminated appraisal) (TA867)

    NICE is unable to make a recommendation on mitapivat (Pyrukynd) for treating pyruvate kinase deficiency in adults because Agios did not provide an evidence submission. We will review this decision if the company decides to make a submission.

    Technology appraisal guidance
    Published
    16 February 2023

    Sections for TA867